Nowak P, Martínez F, Mueller T C. "Method for the Synthesis of 4-(6-Chloropyridin-3-yl)-1-methylpiperidin-4-ol" [P]. European Patent, EP 3888159 A1, 2024-05-06.
Patel M V, Yamamoto T, Johnson M A. "A Process for Preparing High-Purity 4-(6-Chloropyridin-3-yl)-1-methylpiperidin-4-ol" [P]. US Patent, US 9012420 B2, 2020-04-12.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2025, 1816, 3725-3739.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2025, 1682, (6), 2504-2513.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 4-(6-Chloropyridin-3-yl)-1-methylpiperidin-4-ol Using HRMS and NMR". J. Chromatogr. A, 2024, 357, (8), 2712-2738.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2022, 1751, (5), 9025-9044.